Dongbang Medical Co., Ltd (KOSDAQ:240550)
South Korea · Delayed Price · Currency is KRW 8,420.00
+20.00 (0.24%)
At close: Dec 5, 2025
Dongbang Medical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | 9,616 | 2,914 | 9,775 | 3,192 |
Depreciation & Amortization | 6,699 | 6,164 | 5,448 | 5,272 |
Loss (Gain) From Sale of Assets | -347.47 | -1,986 | 102.65 | 28.47 |
Loss (Gain) From Sale of Investments | -1.11 | -1.31 | -1.7 | 3.79 |
Loss (Gain) on Equity Investments | 1,003 | 717.75 | 665.49 | 534.16 |
Stock-Based Compensation | 329 | 401.28 | 601.08 | 480.63 |
Provision & Write-off of Bad Debts | 540.17 | 62.31 | -1,462 | 1,895 |
Other Operating Activities | -68.36 | 12,040 | 4,802 | 1,949 |
Change in Accounts Receivable | -1,968 | -2,521 | 485.17 | -2,442 |
Change in Inventory | -3,508 | -1,604 | -4,460 | -6,410 |
Change in Accounts Payable | 575.01 | 989.57 | -4,413 | 2,453 |
Change in Other Net Operating Assets | 943.99 | 1,420 | -5,266 | 3,518 |
Operating Cash Flow | 13,754 | 18,548 | 6,276 | 10,474 |
Operating Cash Flow Growth | -1.63% | 195.54% | -40.08% | - |
Capital Expenditures | -18,384 | -13,140 | -4,465 | -6,095 |
Sale of Property, Plant & Equipment | 512.77 | 101.25 | 14.98 | 217.75 |
Cash Acquisitions | -641.86 | -3,552 | - | - |
Sale (Purchase) of Intangibles | -442.25 | -40.54 | -209.41 | -187.83 |
Sale (Purchase) of Real Estate | -6.36 | - | - | -112.17 |
Investment in Securities | -15,292 | -11,048 | -3,682 | -62.99 |
Other Investing Activities | -1,837 | -1,586 | 12.81 | 4 |
Investing Cash Flow | -25,195 | -17,676 | -7,731 | -6,712 |
Short-Term Debt Issued | - | 7,000 | 8,207 | 14,678 |
Long-Term Debt Issued | - | 1,483 | 2,900 | 5,070 |
Total Debt Issued | 10,056 | 8,483 | 11,107 | 19,748 |
Short-Term Debt Repaid | - | -5,652 | -9,438 | -17,450 |
Long-Term Debt Repaid | - | -3,319 | -5,195 | -2,367 |
Total Debt Repaid | -13,525 | -8,971 | -14,633 | -19,816 |
Net Debt Issued (Repaid) | -3,469 | -487.88 | -3,526 | -68.17 |
Issuance of Common Stock | 32,041 | 256.61 | 45.47 | - |
Other Financing Activities | 3,262 | 0.92 | -0 | -11,794 |
Financing Cash Flow | 31,835 | -230.35 | -3,481 | 3,138 |
Foreign Exchange Rate Adjustments | 306.85 | 988.15 | -100.04 | 24.76 |
Net Cash Flow | 20,701 | 1,630 | -5,036 | 6,925 |
Free Cash Flow | -4,630 | 5,408 | 1,811 | 4,379 |
Free Cash Flow Growth | - | 198.58% | -58.64% | - |
Free Cash Flow Margin | -4.14% | 5.15% | 1.99% | 5.38% |
Free Cash Flow Per Share | -219.98 | 334.19 | 103.53 | 295.08 |
Cash Interest Paid | 763.34 | 1,219 | 2,058 | 1,113 |
Cash Income Tax Paid | 5,839 | 3,091 | 1,642 | 2,544 |
Levered Free Cash Flow | -10,939 | -13,745 | -1,527 | - |
Unlevered Free Cash Flow | -10,155 | -12,523 | 106.5 | - |
Change in Working Capital | -4,016 | -1,764 | -13,654 | -2,881 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.